Covid

Is the news making us unwell?

Since the start of the pandemic I’ve been observing friends and family and their reactions to the virus. Broadly speaking they fall into two groups; at one end of the spectrum there are the insouciant, apparently unconcerned about a viral threat they think has been exaggerated; at the other are the corona-obsessives who have avidly consumed every scrap of information they can find – of which there has been no shortage. They’ve become minutely informed on everything from T-cells to lateral-flow tests; their lives have been subsumed under a tsunami of technical information. Of the two groups it is the wilfully ignorant who seem happier. The well-informed, who have become

Covid is tearing the Czech Republic apart

The Covid-19 situation is rapidly deteriorating in the Czech Republic, with new efforts to stop the spread of the virus descending into bitter rows and a climate of cynicism and fear. In a government press conference held late on Friday night, harsher measures were announced to tackle the alarming spread of the ‘British variant’ of coronavirus in the Czech Republic. These restrictions included the closure of more shops and services, the closing of primary schools and nurseries, the reintroduction of mandatory face mask wearing outside, and a ban on movement between municipalities. Cases and deaths have risen to new heights in recent weeks, leaving Czech hospitals on the verge of

Steerpike

The New York Times’ orgy of British despair

The New York Times seems to have developed a strange view of Britain in recent years – or at least since the Brexit vote in 2016. In the NYT’s world, the UK is a desolate place, where locals huddle round bin fires on the streets of London, gnawing on legs of mutton and cavorting in swamps during the summer, ever fearful of the despot Prime Minister, Boris Johnson. So Mr S was not exactly surprised to see that the paper’s latest missive from the Covid frontline in Britain, published today, veered on the negative side, detailing the ‘crushing onslaught of a pandemic’ in hospitals, in what can only be described

Is Gavin Williamson doing enough for deprived children?

There are just days until all pupils return to English schools, and Conservative MPs are becoming increasingly concerned about what state many of these students will be in when they arrive back in the classroom after the best part of a year trying to learn from home. At today’s Education Questions in the House of Commons, a number of backbenchers pressed Education Secretary Gavin Williamson on the work the government is doing to get the most disadvantaged children back up to speed. Both Jack Brereton and Julian Sturdy had tabled questions asking ‘what support his department is providing to help children catch up on lost learning during the Covid-19 outbreak’.

James Forsyth

Oxford’s remarkable vaccine success

It is worth taking a moment to stand back and applaud Sarah Gilbert and the Oxford vaccine team’s achievement. The data released this evening by Public Health England shows that a single dose of both the Oxford /AstraZeneca vaccine and the Pfizer vaccine cuts the risk of hospitalisation by 80 per cent in the over-80s, the most vulnerable group. It also suggests that the Oxford one, despite its messy trial data, is slightly more effective than the Pfizer vaccine in preventing symptomatic infection among the over-70s. The efficacy of the Oxford vaccine has completely changed the outlook for the UK. This country has enough doses of it ordered to cover

Katy Balls

The UK’s Covid strategy gets a vaccine boost

Matt Hancock had good news for today’s press conference: the Health Secretary said the effectiveness of vaccines was beginning to show in the data. While hospitalisations are falling across the board, they are falling the fastest among the priority groups that have received the vaccine. Deputy Chief Medical officer Jonathan Van-Tam said that both the Oxford/AstraZeneca and Pfizer vaccine are reducing hospitalisations by 80 per cent in the over-70s. Hancock said that the most recent data showed that protection from the Oxford vaccine after 35 days is even greater than Pfizer – though both vaccines produce an 80 per cent reduction in hospitalisations. He said the vaccine results could ‘help

Can the EU be trusted to introduce vaccine passports?

The contracts were badly drafted. The orders were late. Too few resources were made available for the scale of the task, and the regulators dithered and delayed. Even the most fanatical federalists such as Guy Verhofstadt have admitted the EU’s vaccine programme was little short of a catastrophe. But hey, what does that matter? Ursula von der Leyen has decided this is the moment to double down on the EU’s Covid-19 strategy, and launch a centralised vaccine passport. What could possibly go wrong? Well, er, as the EU’s vaccine fiasco has taught us, lots actually. Von der Leyen has today tried to bounce back from her difficulties with the vaccine

The battle for the soul of the Jewish community

There are two groups in the Jewish community – mainstream Jews who, while still religious, do their best to assimilate into the wider community and the Chareidi, ultra-orthodox Jews who tend to shun British society. Those two groups are now locked in a struggle for the future of the Jewish community. For over 100 years, the Chareidi – with their distinctive costume, based on the fashions of 18th century Poland – have had a sort of symbiotic relationship with the mainstream. If mainstream Jews needed kosher slaughterers, rabbinical judgements, circumcisions and even rabbis for the smaller pulpits, they relied on the Chareidi. They were the ones with an encyclopaedic knowledge

What Angela Merkel can learn from the Queen about vaccine scepticism

You have to feel for Germany. After a fraught vaccine procurement process, not only is the government struggling to persuade its citizens to take the Oxford AstraZeneca vaccine, but Angela Merkel has now stated that she will not be given the jab on account of her age.  ‘I do not belong to the recommended age group for AstraZeneca,’ the German chancellor told Frankfurter Allgemeine Zeitung newspaper. It could well be the final nail in the coffin for an EMA-approved, safe vaccine that has cost her country millions. Merkel’s view may be aligned with government policy – she is 66 and therefore, under the German rules which state that over 65s

Why do old people have fewer antibodies after the vaccine?

The UK policy of delaying second doses of the Pfizer vaccine has been criticised by some as risky, with Pfizer warning that there is no data on the effectiveness of its vaccine other than for the dosing regime used in phase 3 trials: two doses, 21 days apart. But evidence is steadily trickling through. Earlier in the week I wrote here about the Scottish population-wide study which found that a single dose of the Pfizer vaccine reduced hospital admissions by 85 per cent between 28 and 34 days after the jab. This morning comes Imperial College’s React-2 study, which paints a picture that is, on the face of it, rather less

Boris’s lockdown speech was classic Blairite triangulation

Several of Tony Blair’s ideas have found their way into the government’s Covid policy, most notably the policy of prioritising first doses. The end of Boris Johnson’s statement today owed a lot to Blair. Johnson cast himself as charting a middle course between those who think the government’s plan is too ambitious and those who want restrictions eased faster. It was classic Blairite triangulation. The road map is an interesting document. It is initially cautious and the decision to put five weeks between easing measures means that we won’t be able to sit inside a pub until 17 May, a long way from the idea that things would be heading

James Forsyth

Will the vaccine reduce public support for lockdown?

The vaccine news today is good, and better than would have been expected even a month ago. The Public Health Scotland data indicating that four weeks after the first dose of the Oxford / AstraZeneca vaccine there is a 94 per cent reduction in the risk of hospitalisation is phenomenal (the figure for Pfizer/BioNTech is 85 per cent). It suggests that the vaccines should deliver on the ‘protect the NHS’ part of the government’s strategy. This will lead to more Tory pressure on Boris Johnson for a faster easing of lockdown. The argument will go that given the data is better than expected, the pace of lockdown easing should be sped

When will vaccines let us reopen society?

With every passing day, more Covid immunity is being gained as hundreds of thousands receive the vaccine. Of course, vaccines take time to mature in the body and offer protection, but with roughly a quarter of the population having now received their first inoculation, our approach to dealing with the virus will inevitably need to shift. The big question is how vaccination has changed the equation for how quickly society can be reopened. Modelling from the PCCF project at Bristol University, on cautious assumptions, suggests that the pace of the vaccine rollout would allow significant reopening with herd immunity achieved in July. First, let’s say how much vaccine immunity has

Does this Israeli study support Britain’s one-dose strategy?

Is the British approach of prioritising first doses of Covid vaccines and not promising a second dose until 12 weeks later compromising our ability to fight the disease? It is not a moot point, with several EU figures asserting that it is a risky route to take. As I wrote here a couple of weeks ago, as far as the AstraZeneca/Oxford vaccine is concerned, what evidence we have supports the practice of delaying a second dose until 12 weeks after the first one; the vaccine is more effective that way. However, a question mark has continued to hang over the Pfizer/BioNTech vaccine. There is limited data on the most effective

Why Eastern Europe is looking to Russia and China for vaccines

With Central and Eastern European countries still gripped by Covid-19, the EU’s slow vaccine rollout has offered little solace in the region. The light at the end of the tunnel seems far away, leading many to wonder whether the answer to vaccine shortages lies not in Brussels, but to the East. Interest in Russian and Chinese vaccines is certainly fast becoming a diplomatic issue for the region. Czech Prime Minister Andrej Babiš recently caused a stir with two international visits. The first was to his Visegrád Four ally Hungary, the second to non-EU Serbia, far and away mainland Europe’s vaccine leader: Babiš suggested both trips were made with the intention

Britain should follow France and Spain’s lead on school closures

This pandemic has not been short of unexpected twists. Perhaps the most surprising of them all has been Britain’s willingness to close its schools. Boris Johnson’s reasoning for his U-turn in January seemed paradoxical at best: despite judging schools ‘safe’, he closed them anyway. Even more incredibly, the bulk of British parents have been supportive of his decision. On this issue, at least, is it time to take our lead from Europe? While Britain has outpaced Europe in its vaccine roll-out, the attitude towards schooling on the continent has been much bolder than our own. Schools have remained open in both France and Spain throughout the winter, despite both countries

Is Boris Johnson opening the way for vaccine passports?

The government’s position on vaccine passports is a cause of continuing intrigue. Although Downing Street has insisted on several occasions that they will not be brought in domestically, there have been several statements that suggest otherwise. As well as looking at vaccine passports for international transport, Dominic Raab appeared to at least entertain the idea of vaccine certification when it comes to reopening hospitality. Speaking at Monday’s press conference, Boris Johnson sought once again to offer assurances on the issue. Rather than domestic vaccine passports, he said that in terms of reopening the economy, mass vaccination and testing would be the go-to mechanisms. The Prime Minister said that when it

‘Then the roof fell in’: My Covid fight

There was all this talk about Covid, claiming that chaps who were over seventy and not underweight were vulnerable. I would nod sagely, never thinking that this could apply to me. Like a lot of men, when it comes to physique or romance I have a secret appeal court, to override the harsh judgments of birth dates and the shaving mirror. It assured me that I would not catch Covid.  Yet around the turn of the year, I kept on getting intimations and twinges. Full-blown Covid symptoms? No. Taste? Fine. Smell? Fine. Occasional cough but hardly so you would notice. But I was not happy. Was this plague, or hypochondria?